Cytek Biosciences (CTKB) Competitors $3.78 -0.31 (-7.58%) Closing price 04:00 PM EasternExtended Trading$3.80 +0.02 (+0.53%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTKB vs. TXG, EYPT, ALNT, AEHR, TRNS, LAB, SENS, FEIM, QSI, and QTRXShould you be buying Cytek Biosciences stock or one of its competitors? The main competitors of Cytek Biosciences include 10x Genomics (TXG), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Transcat (TRNS), Standard BioTools (LAB), Senseonics (SENS), Frequency Electronics (FEIM), Quantum-Si (QSI), and Quanterix (QTRX). These companies are all part of the "measuring and control equipment" industry. Cytek Biosciences vs. Its Competitors 10x Genomics Eyepoint Pharmaceuticals Allient Aehr Test Systems Transcat Standard BioTools Senseonics Frequency Electronics Quantum-Si Quanterix 10x Genomics (NASDAQ:TXG) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Do analysts prefer TXG or CTKB? 10x Genomics presently has a consensus target price of $13.65, indicating a potential upside of 4.71%. Cytek Biosciences has a consensus target price of $5.60, indicating a potential upside of 48.15%. Given Cytek Biosciences' higher possible upside, analysts plainly believe Cytek Biosciences is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 1 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33Cytek Biosciences 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Does the media prefer TXG or CTKB? In the previous week, 10x Genomics had 11 more articles in the media than Cytek Biosciences. MarketBeat recorded 13 mentions for 10x Genomics and 2 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 1.71 beat 10x Genomics' score of 0.94 indicating that Cytek Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 6 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cytek Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals have more ownership in TXG or CTKB? 84.7% of 10x Genomics shares are owned by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are owned by institutional investors. 9.4% of 10x Genomics shares are owned by insiders. Comparatively, 10.3% of Cytek Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, TXG or CTKB? 10x Genomics has a beta of 2, meaning that its share price is 100% more volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Which has higher earnings and valuation, TXG or CTKB? Cytek Biosciences has lower revenue, but higher earnings than 10x Genomics. Cytek Biosciences is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.78M2.66-$182.63M-$0.70-18.63Cytek Biosciences$200.45M2.40-$6.02M-$0.05-75.60 Is TXG or CTKB more profitable? Cytek Biosciences has a net margin of -3.27% compared to 10x Genomics' net margin of -13.13%. Cytek Biosciences' return on equity of -1.66% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-13.13% -12.88% -10.03% Cytek Biosciences -3.27%-1.66%-1.30% Summary10x Genomics and Cytek Biosciences tied by winning 8 of the 16 factors compared between the two stocks. Get Cytek Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CTKB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTKB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTKB vs. The Competition Export to ExcelMetricCytek BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$480.89M$3.13B$5.76B$10.42BDividend YieldN/A2.37%5.74%4.63%P/E Ratio-75.6020.6576.5526.73Price / Sales2.40386.12496.21162.19Price / Cash112.9645.3237.1760.63Price / Book1.239.6613.726.40Net Income-$6.02M-$53.02M$3.29B$271.62M7 Day Performance-4.06%1.09%1.03%2.85%1 Month Performance-6.44%7.93%6.32%9.64%1 Year Performance-28.54%10.48%81.16%31.62% Cytek Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTKBCytek Biosciences1.9851 of 5 stars$3.78-7.6%$5.60+48.1%-19.2%$480.89M$200.45M-75.60500Positive NewsTXG10x Genomics3.6019 of 5 stars$13.93-0.2%$13.54-2.8%-39.9%$1.74B$610.78M-19.901,240EYPTEyepoint Pharmaceuticals1.741 of 5 stars$13.65-2.6%$26.86+96.8%+54.4%$965.67M$51.90M-5.09120Positive NewsALNTAllient2.6392 of 5 stars$45.76+0.5%$35.00-23.5%+133.1%$771.77M$529.97M53.212,525Positive NewsAEHRAehr Test Systems1.9413 of 5 stars$25.19-1.4%N/A+152.6%$764.63M$58.97M-193.7590TRNSTranscat3.8462 of 5 stars$79.71+2.0%$112.20+40.8%-41.0%$728.57M$278.42M55.741,245Positive NewsShort Interest ↑LABStandard BioTools2.5559 of 5 stars$1.36+4.6%$1.55+14.0%-30.5%$496.59M$174.43M-4.25620Positive NewsHigh Trading VolumeSENSSenseonics1.9537 of 5 stars$0.44-3.0%$1.54+246.6%+11.0%$361.39M$25.47M-3.4190FEIMFrequency Electronics3.1015 of 5 stars$32.64+3.3%N/A+157.3%$308.08M$69.81M13.21200Analyst ForecastQSIQuantum-Si1.895 of 5 stars$1.06-1.9%$3.48+227.8%+53.0%$218.70M$3.06M-1.56150Gap DownQTRXQuanterix1.8254 of 5 stars$4.52-0.7%$11.75+160.0%-60.5%$211.42M$137.42M-2.48460Positive News Related Companies and Tools Related Companies 10x Genomics Alternatives Eyepoint Pharmaceuticals Alternatives Allient Alternatives Aehr Test Systems Alternatives Transcat Alternatives Standard BioTools Alternatives Senseonics Alternatives Frequency Electronics Alternatives Quantum-Si Alternatives Quanterix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTKB) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytek Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytek Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
